Overview
Deaf blind hypopigmentation syndrome, Yemenite type (also known as Yemenite deaf-blind hypopigmentation syndrome or Warburg-Thomsen syndrome) is an extremely rare genetic disorder first described in Yemenite Jewish families. The condition is characterized by a triad of features affecting the eyes, ears, and skin pigmentation. Key ocular findings include microcornea, coloboma (a gap in structures of the eye such as the iris, choroid, or retina), and other anterior chamber anomalies, which can lead to significant visual impairment or blindness. Sensorineural hearing loss, which may be severe to profound, is another hallmark of the syndrome. Cutaneous hypopigmentation manifests as patchy depigmented areas of the skin, and patients may also exhibit hypopigmented patches of hair, resembling features seen in Waardenburg syndrome. The syndrome affects multiple body systems, primarily the sensory organs (eyes and ears) and the integumentary system (skin and hair). Some patients may also have additional features such as intellectual disability, though this is not uniformly present. The condition is thought to result from abnormal development and migration of neural crest cells, which contribute to melanocytes, inner ear structures, and parts of the eye during embryonic development. Due to the extreme rarity of this condition, there is no specific targeted therapy. Management is supportive and multidisciplinary, involving ophthalmologic care, hearing aids or cochlear implants for hearing loss, dermatologic monitoring, and developmental support as needed. Genetic counseling is recommended for affected families.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Deaf blind hypopigmentation syndrome, Yemenite type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Deaf blind hypopigmentation syndrome, Yemenite type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Deaf blind hypopigmentation syndrome, Yemenite type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Deaf blind hypopigmentation syndrome, Yemenite type.
Community
No community posts yet. Be the first to share your experience with Deaf blind hypopigmentation syndrome, Yemenite type.
Start the conversation →Latest news about Deaf blind hypopigmentation syndrome, Yemenite type
No recent news articles for Deaf blind hypopigmentation syndrome, Yemenite type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Deaf blind hypopigmentation syndrome, Yemenite type
What is Deaf blind hypopigmentation syndrome, Yemenite type?
Deaf blind hypopigmentation syndrome, Yemenite type (also known as Yemenite deaf-blind hypopigmentation syndrome or Warburg-Thomsen syndrome) is an extremely rare genetic disorder first described in Yemenite Jewish families. The condition is characterized by a triad of features affecting the eyes, ears, and skin pigmentation. Key ocular findings include microcornea, coloboma (a gap in structures of the eye such as the iris, choroid, or retina), and other anterior chamber anomalies, which can lead to significant visual impairment or blindness. Sensorineural hearing loss, which may be severe to
How is Deaf blind hypopigmentation syndrome, Yemenite type inherited?
Deaf blind hypopigmentation syndrome, Yemenite type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Deaf blind hypopigmentation syndrome, Yemenite type typically begin?
Typical onset of Deaf blind hypopigmentation syndrome, Yemenite type is neonatal. Age of onset can vary across affected individuals.